Impact of endurance and strength training on left ventricular systolic function in hypertensive patients

Impact of endurance and strength training on left ventricular systolic function in hypertensive patients: A single-blind randomized controlled trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202006810274251

Enrollment

Registered

2020-06-24

Start date

2020-02-10

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiology

Interventions

strength training

endurance training

control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: they had stable primary hypertension that was pharmacologically controlled with no modification during the intervention or follow-up, they had no evidence of diabetes mellitus or other systemic diseases apart from hypertension for at least the past six months, they had a quiescent lifestyle.

Exclusion criteria

Exclusion criteria: Patients with secondary hypertension LV wall motion abnormality or impaired LV ejection fraction <45% heart failure, heart valvular disease, coronary artery disease, cardiac arrhythmia, previous stroke, diabetes mellitus evidence of severe cerebrovascular disorder profound musculoskeletal challenges limiting their physical fitness

Design outcomes

Primary

Measure	Time frame
Left Ventricular Ejection Fraction (LVEF) and Left Ventricular Fractional Shortening (LVFS)	—

Secondary

Measure	Time frame
Left Ventricular End Diastolic Diameter (LVEDD)	—

Countries

Egypt

Contacts

Public ContactMona Taha

associate professor of physical therapy Cairo University

Monady2007@yahoo.com00201111351518

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026